Project Khanya: results from a pilot randomized type 1 hybrid effectiveness-implementation trial of a peer-delivered behavioural intervention for ART adherence and substance use in HIV care in South Africa.

Journal: Journal of the International AIDS Society

Volume: 24 Suppl 2

Issue: Suppl 2

Year of Publication: 2021

Affiliated Institutions:  Department of Psychology, University of Maryland, College Park, MD, USA. HIV Mental Health Research Unit, Division of Neuropsychiatry, Department of Psychiatry and Mental Health, Groote Schuur Hospital, Cape Town, South Africa. Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Division of Addiction Psychiatry, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa. Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. Department of Psychology, University of Miami, Miami, FL, USA.

Abstract summary 

South Africa (SA) has the highest number of people living with HIV (PLWH) globally, and a significant burden of alcohol and other drug use (AOD). Although integrating AOD treatment into HIV care may improve antiretroviral therapy (ART) adherence, this is not typically routine practice in SA or other low-resource settings. Identifying interventions that are feasible and acceptable for implementation is critical to improve HIV and AOD outcomes.A pilot randomized hybrid type 1 effectiveness-implementation trial (N = 61) was conducted to evaluate the feasibility and acceptability of Khanya, a task-shared, peer-delivered behavioral intervention to improve ART adherence and reduce AOD in HIV care in SA. Khanya was compared to enhanced treatment as usual (ETAU), a facilitated referral to on-site AOD treatment. Implementation outcomes, defined by Proctor's model, included feasibility, acceptability, appropriateness and fidelity. Primary pilot effectiveness outcomes were ART adherence at post-treatment (three months) measured via real-time electronic adherence monitoring, and AOD measured using biomarker and self-report assessments over six months. Data collection was conducted from August 2018 to April 2020.Ninety-one percent of participants (n = 56) were retained at six months. The intervention was highly feasible, acceptable, appropriate and delivered with fidelity (>90% of components delivered as intended by the peer). There was a significant treatment-by-time interaction for ART adherence (estimate = -0.287 [95% CI = -0.507, -0.066]), revealing a 6.4 percentage point increase in ART adherence in Khanya, and a 22.3 percentage point decline in ETAU. Both groups evidenced significant reductions in alcohol use measured using phosphatidylethanol (PEth) (F(2,101) = 4.16, p = 0.01), significantly decreased likelihood of self-reported moderate or severe AOD (F(2,104) = 7.02, p = 0.001), and significant declines in alcohol use quantity on the timeline follow-back (F(2,102) = 21.53, p < 0.001). Among individuals using drugs and alcohol, there was a greater reduction in alcohol use quantity in Khanya compared to ETAU over six months (F(2,31) = 3.28, p = 0.05).Results of this pilot trial provide initial evidence of the feasibility and acceptability of the Khanya intervention for improving adherence in an underserved group at high risk for ongoing ART non-adherence and HIV transmission. Implementation results suggest that peers may be a potential strategy to extend task-sharing models for behavioral health in resource-limited, global settings.

Authors & Co-authors:  Magidson Jessica F JF Joska John A JA Belus Jennifer M JM Andersen Lena S LS Regenauer Kristen S KS Rose Alexandra L AL Myers Bronwyn B Majokweni Sybil S O'Cleirigh Conall C Safren Steven A SA

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Statistics South Africa. 2020 Mid‐year population estimates [Internet]. 2020. [cited 2020 Aug 24]. Available from: http://www.statssa.gov.za/?p=13453
Authors :  10
Identifiers
Doi : e25720
SSN : 1758-2652
Study Population
Male,Female
Mesh Terms
HIV Infections
Other Terms
HIV;South Africa;antiretroviral therapy adherence;global mental health;implementation science;substance use
Study Design
Randomized Control Trial,Cross Sectional Study
Study Approach
Country of Study
South Africa
Publication Country
Switzerland